Kl. Geris et al., PITUITARY AND EXTRAPITUITARY ACTION SITES OF THE NOVEL NONPEPTIDYL GROWTH-HORMONE (GH) SECRETAGOGUE L-692,429 IN THE CHICKEN, General and comparative endocrinology (Print), 111(2), 1998, pp. 186-196
Chickens were used as a model to further analyze the efficacy and spec
ificity of L-692,429, a novel nonpeptidyl mimic of growth hormone (GH)
-releasing peptide-6 (GHRP-6), which is a specific GH-releasing secret
agogue in mammals. Actions at the level of the pituitary and the hypot
halamus were studied. Pituitaries isolated from 1-day-old (Cl) chicks
responded in a dose-dependent manner to L-692,429 (ED50 = 10 nM). Usin
g equimolar concentrations of thyrotropin-releasing hormone (TRH), hum
an GH-releasing hormone (hGHRH(1-29)), and L-692,429 (10 nM), L-692,42
9 had 20-25% the in vitro potency of the two endogenous releasing fact
ors. There was an additive effect between hGHRH(1-29), (10 nM) and L-6
92,429 (10 or 100 nM) on GH release from C1 pituitaries but no such ad
ditive effect was observed when pituitaries were exposed to both TRH (
10 nM) and L-692,429 (100 nM). An acute challenge with 50 mu g L-692,4
29 resulted in increased plasma GH levels within 5 min, which remained
elevated for up to 15 min (Cl chickens). This increase in GH was acco
mpanied by a drop in hypothalamic TRH content by 5 min. Hypothalamic s
omatostatin (SRIH) content did not change. Plasma corticosterone conce
ntrations were increased following L-692,429 treatment, whereas plasma
alpha-subunit, T-4, and T-3 levels were unchanged. To confirm the rol
e of the decreased hypothalamic TRH concentrations in the GH-releasing
activity of L-692,429 in the chicken, chickens (C1) were pretreated w
ith normal rabbit serum (NRS) or a TRH antiserum (1/50) 1 h prior to t
he L-692,429 challenge. Both groups showed an increase in circulating
GPI but the increase was within 5 min inhibited by the TRH antiserum p
retreatment, whereas no differences were noted in plasma corticosteron
e levels. It is concluded that in the chicken the GH secretagogue L-69
2,429 has a dual action site: (1) directly at the level of the pituita
ry and (2) centrally through an increase in hypothalamic TRH release.
(C) 1908 Academic Press.